Renu Juneja is Head of the Scientific Evidence and Communications function in US Medical Affairs Oncology at Janssen Biotechnology Inc (JBI). Before joining Janssen, Renu was head of the Medical Communications group at MedImmune (the worldwide biologics research and development arm of AstraZeneca).
Previously, she was at Novo Nordisk for 16 years and grew from a medical writer role to a leadership role to head the Strategic Scientific Communication (SSC) group. After finishing her PhD in Reproductive Biology and Biochemistry from the Post-Graduate Institute of Medical Education and Research (PGIMER) in India, Renu joined The Population Council in NY as a Postdoctoral fellow. Two years later, she received an independent research grant from the Lalor Foundation and joined the department of Molecular Biology at the Princeton University. She has over 25 publications in peer-reviewed journals and has presented at various national and international conferences.
Renu has presented and conducted workshops at the annual meetings of various professional organizations e.g., ISMPP, TIPPA, CBI, and Q1 productions. Since July, 2020, she is co-leading the Medical Communications workstream for the Medical Affairs Professional Society (MAPS).